A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician's Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously Untreated Patients with TP53 Mutant Acute Myeloid Leukemia

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Hodges, Georgina (Chief Investigator (CI))
  • Purtill, Duncan (Chief Investigator (CI))
  • Bennett, Sam (Chief Investigator (CI))
  • Hiwase, Devendra Keshaorao (Chief Investigator (CI))
  • Tate, Courtney (Chief Investigator (CI))
  • Enjeti, Anoop (Chief Investigator (CI))
  • Bhattacharyya, Abir (Chief Investigator (CI))
  • Tan, Peter (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date31/08/2131/12/24


  • Acute Myeloid Leukemia
  • Haematological malignancy
  • Clinical trial
  • Blood cancer